Limit private equity ownership and require disclosure
Ownership disclosure, review of roll-ups, limits on sale-leasebacks, and liability for owners when facilities are stripped.
Targets asset stripping and roll-ups.
Review ledgerHow this path connects
Addresses
Private equity roll-ups in medicineThis path
Limit private equity ownership and require disclosure
Concrete changes if chosen
What would actually have to change in law, agencies, payment rules, or systems.
- Require ownership disclosure for all providers
- Ban corporate control of medical decisions
- Limit sale-leasebacks
- Make owners liable for stripped assets
Effects
Each effect has its own page: the evidence, the case that it is or isn't a real cost, and whom it affects.
What it fixes
- Private equity roll-ups in medicine
Ownership disclosure, acquisition review, sale-leaseback limits, and owner liability target asset stripping and make ownership visible to regulators and patients.
What it creates or worsens
- Under-investment in equipment and facilities
Ownership restrictions reduce capital available to practices.
- Requires difficult enforcement
Owners may restructure to evade the rules.
Who's affected
Who gains
- People with ongoing or specialist care needs
- Private equity roll-ups in medicine: Practice and facility buyouts can raise prices and cut staff.
- Older and disabled people needing long-term care
- Private equity roll-ups in medicine: Practice and facility buyouts can raise prices and cut staff.
- Doctors, nurses, and other clinicians
- Private equity roll-ups in medicine: Private equity ownership reduces their autonomy.
- Taxpayers and public budgets
- Under-investment in equipment and facilities: Restrained capital investment limits spending in the short term.
Who loses
- Private equity firms and investors
- Private equity roll-ups in medicine: Investors gain from buying and consolidating medical businesses.
- People with ongoing or specialist care needs
- Under-investment in equipment and facilities: Underinvestment in diagnostic equipment leaves them waiting for tests.
Where it has been tried
- Oregon (2025): Law restricting corporate control of medical practices.